// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Neuroprotective Effect of Nattokinase Mediated by Inhibition of Platelet Aggregation and Thrombosis in Photothrombotic Stroke

Maya Hwewon Kim - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

A Simple Score for Prediction of Outcome after Cerebral Venous Thrombosis

Erwin Chiquete - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Assessment of a New Method of Warfarin Management vs the New Oral Anticoagulants and Conventional Warfarin Management in Atrial Fibrillation

Edith Nutescu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Symptom Severity of Recent Stroke and Risk of Recurrent Vascular Events

Bruce Ovbiagele - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Platelet Extracellular-signal-regulated Kinase 5 is a Redox Switch which Regulates Myocardial Infarct Expansion via Matrix Metalloproteinases

Sara K Ture - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Evithrom

Evaluation of US Prescription Patterns: Are Treatment Guidelines For Cancer-associated Venous Thromboembolism (VTE) Followed?

Daniel Yannicelli - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Warfarin

A Feasibility and Safety Pilot Clinical Trial of Single-dose, Intravenous Estrogen for Resuscitation of Traumatic Hemorrhagic Shock: The RESCUE - Shock Study

Kareem Abdelfattah - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Hydroxyzine

The Response of an in vitro Cynomolgus Macaque System to Statin Treatments Mirrors the Human in vitro System and Clinical Outcomes

Ryan Feaver - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Atorvastatin

VAMP8 Mediates Endothelial Granule Exocytosis

Clare Bao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Antithrombin Perfluorocarbon Nanoparticles Ameliorate Renal Injury Following Transient Warm Ischemia

Junjie Chen - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

Endothelial Dysfunction Potentiates Deep Venous Thrombosis in a Mouse Model of Sepsis

Chase W Kessinger - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

Elaszym

Development and Proof of Concept Testing of an Ex Vivo Perfusion Chamber for Studying Platelet Adhesion to Coronary Stents Under Physiological Conditions

Hayden Kelly - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

A Biomimetic Approach to Developing Antithrombotic Small-Caliber Prosthetic Vascular Grafts

Ifeanyi U Onyejekwe - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitric oxide

Circulating Endothelial Microparticles, Elevated Blood Pressure and Endothelin-1 Mediated Vasoconstrictor Tone

Tyler D Bammer - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

endothelin-1

Ischemic Stroke Following Discontinuation of Antiplatelet Therapy in Essential Thrombocythemia: A Case Report

Shanjin Cao - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Hydroxyurea

Gestational Inflammation and Perinatal Arterial Ischemic Stroke: A Causal Connection?

Nicole Cauchon - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Device-Relevant Dynamic and Constant Shear Stresses Induce Prothrombotic Platelet- and Monocyte-Derived Microparticles

Robin M Kamucheka - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Evithrom

The Effects of Diet on Occlusive Coronary Artery Atherosclerosis, Thrombosis and Myocardial Infarction in SR-BI/LDL Receptor Double KO Mice

Bernardo L Trigatti - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

cholic acid

Poor Progression of in-Stent Neoatherosclerosis in Patients With Everolimus-Eluting Stent Implantation: Coronary Angioscopic Observation

Shohei Yoshima - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Circulating Alpha-2-Antiplasmin Affects Microvascular Thrombosis, Ischemic Neurodegeneration and Mortality in Mice Following Cerebral Thromboembolism

Aiilyan Houng - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved